Dot blot analysis of rhodamine (row 1) and streptavidin (row 2) using GTX29093 Rhodamine antibody [11H10]. Lane 1 : 100 ng Lane 2 : 33.3 ng Lane 3 : 11.1 ng Lane 4 : 3.7 ng Lane 5 : 1.23 ng Dilution : 1:1000
Dot blot analysis of rhodamine (row 1) and streptavidin (row 2) using GTX29093 Rhodamine antibody [11H10]. Lane 1 : 100 ng Lane 2 : 33.3 ng Lane 3 : 11.1 ng Lane 4 : 3.7 ng Lane 5 : 1.23 ng Dilution : 1:1000
Rhodamine antibody [11H10]
GTX29093
ApplicationsDot Blot, Western Blot, ELISA, ImmunoHistoChemistry, Other Application
Product group Antibodies
ReactivityOther Species
Overview
- SupplierGeneTex
- Product NameRhodamine antibody [11H10]
- Delivery Days Customer9
- Antibody SpecificityRHODAMINE Monoclonal Antibody was protein A purified and reacts specifically with Rhodamine and its derivatives. Rhodamine isomer 5 and isomer 6 are reactive as TAMRA, as well as TRITC conjugated proteins. No reaction is observed against Texas Red.
- Application Supplier NoteWB: 1:1000-1:10000. ELISA: 1:10000-1:30000. IHC: 1:1000-10000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsDot Blot, Western Blot, ELISA, ImmunoHistoChemistry, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID11H10
- Concentration1.05 mg/ml
- ConjugateUnconjugated
- HostMouse
- IsotypeIgG1
- Scientific DescriptionRHODAMINE Monoclonal Antibody specifically detect dyes in the Rhodamine family. Rhodamine is a family member of the fluorone dyes. Examples are Rhodamine 6G and Rhodamine B. They are often used as a tracer dye within water to determine the rate and direction of flow and transport. Rhodamine dyes fluoresce and can thus be detected easily and inexpensively with instruments called fluorometers. Rhodamine dyes are used extensively in biotechnology applications such as fluorescence microscopy, flow cytometry, fluorescence correlation spectroscopy and ELISA.
- ReactivityOther Species
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Tau oligomers mediate alpha-synuclein toxicity and can be targeted by immunotherapy. Gerson JE et al., 2018 Mar 15, Mol NeurodegenerRead more
- Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimers disease mouse model. Castillo-Carranza DL et al., 2015 Mar 25, J NeurosciRead more
- Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles. Castillo-Carranza DL et al., 2014 Mar 19, J NeurosciRead more
- Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds. Castillo-Carranza DL et al., 2014, J Alzheimers DisRead more